
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6506068
[patent_doc_number] => 20100216115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 12/644883
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17721
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216115.pdf
[firstpage_image] =>[orig_patent_app_number] => 12644883
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/644883 | METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS | Dec 21, 2009 | Abandoned |
Array
(
[id] => 6231436
[patent_doc_number] => 20100184671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Binding molecules for the treatment of myeloid cell malignancies'
[patent_app_type] => utility
[patent_app_number] => 12/653779
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 28247
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184671.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653779
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653779 | Binding molecules for the treatment of myeloid cell malignancies | Dec 17, 2009 | Issued |
Array
(
[id] => 6425948
[patent_doc_number] => 20100151501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'Forms of Prostate Specific Antigens and Methods for their Detection'
[patent_app_type] => utility
[patent_app_number] => 12/632640
[patent_app_country] => US
[patent_app_date] => 2009-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15687
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151501.pdf
[firstpage_image] =>[orig_patent_app_number] => 12632640
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/632640 | Forms of Prostate Specific Antigens and Methods for their Detection | Dec 6, 2009 | Abandoned |
Array
(
[id] => 6436558
[patent_doc_number] => 20100143927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Methods and Assays for Measuring p95 and/or p95 in a Sample and Antibodies Specific for p95'
[patent_app_type] => utility
[patent_app_number] => 12/629037
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 28805
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143927.pdf
[firstpage_image] =>[orig_patent_app_number] => 12629037
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/629037 | Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 | Nov 30, 2009 | Issued |
Array
(
[id] => 6356512
[patent_doc_number] => 20100086985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 205P1B5 USEFUL IN TREATMENT AND DETECTION OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/627998
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 69338
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086985.pdf
[firstpage_image] =>[orig_patent_app_number] => 12627998
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/627998 | NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 205P1B5 USEFUL IN TREATMENT AND DETECTION OF CANCER | Nov 29, 2009 | Abandoned |
Array
(
[id] => 6270884
[patent_doc_number] => 20100255006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'NOVEL MOLECULES OF THE PYRIN/NBS/LRR PROTEIN FAMILY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/627191
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 64480
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20100255006.pdf
[firstpage_image] =>[orig_patent_app_number] => 12627191
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/627191 | NOVEL MOLECULES OF THE PYRIN/NBS/LRR PROTEIN FAMILY AND USES THEREOF | Nov 29, 2009 | Abandoned |
Array
(
[id] => 6436549
[patent_doc_number] => 20100143926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Classification of Patients Having Diffuse Large B-cell Lymphoma Based upon Gene Expression'
[patent_app_type] => utility
[patent_app_number] => 12/625523
[patent_app_country] => US
[patent_app_date] => 2009-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7368
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143926.pdf
[firstpage_image] =>[orig_patent_app_number] => 12625523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/625523 | Classification of Patients Having Diffuse Large B-cell Lymphoma Based upon Gene Expression | Nov 23, 2009 | Abandoned |
Array
(
[id] => 8625157
[patent_doc_number] => 08357652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-22
[patent_title] => 'Anti-tumor fibrillar human serum albumin methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 12/623162
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 7713
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12623162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/623162 | Anti-tumor fibrillar human serum albumin methods and compositions | Nov 19, 2009 | Issued |
Array
(
[id] => 6314312
[patent_doc_number] => 20100111969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS'
[patent_app_type] => utility
[patent_app_number] => 12/609309
[patent_app_country] => US
[patent_app_date] => 2009-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7697
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12609309
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/609309 | IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS | Oct 29, 2009 | Abandoned |
Array
(
[id] => 9046990
[patent_doc_number] => 08541544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Molecular marker for cancer stem cell'
[patent_app_type] => utility
[patent_app_number] => 13/126039
[patent_app_country] => US
[patent_app_date] => 2009-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 34
[patent_no_of_words] => 15515
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126039
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/126039 | Molecular marker for cancer stem cell | Oct 26, 2009 | Issued |
Array
(
[id] => 6430655
[patent_doc_number] => 20100152058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'CANCER MARKERS'
[patent_app_type] => utility
[patent_app_number] => 12/576812
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 26359
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152058.pdf
[firstpage_image] =>[orig_patent_app_number] => 12576812
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/576812 | Cancer markers | Oct 8, 2009 | Issued |
Array
(
[id] => 8760267
[patent_doc_number] => 08420788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Epitopes derived from SATB2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/062820
[patent_app_country] => US
[patent_app_date] => 2009-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 21431
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062820
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/062820 | Epitopes derived from SATB2 and uses thereof | Oct 5, 2009 | Issued |
Array
(
[id] => 6485362
[patent_doc_number] => 20100092978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'CADHERIN-17 AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR LIVER CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/569386
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 35688
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12569386
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/569386 | Cadherin-17 as diagnostic marker and therapeutic target for liver cancer | Sep 28, 2009 | Issued |
Array
(
[id] => 6607184
[patent_doc_number] => 20100099102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients'
[patent_app_type] => utility
[patent_app_number] => 12/568538
[patent_app_country] => US
[patent_app_date] => 2009-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3417
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099102.pdf
[firstpage_image] =>[orig_patent_app_number] => 12568538
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/568538 | Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients | Sep 27, 2009 | Abandoned |
Array
(
[id] => 6376742
[patent_doc_number] => 20100076175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'MOLECULES THAT SELECTIVELY HOME TO VASCULATURE OF PREMALIGNANT OR MALIGNANT LESIONS OF THE PANCREAS AND OTHER ORGANS'
[patent_app_type] => utility
[patent_app_number] => 12/559305
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19558
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076175.pdf
[firstpage_image] =>[orig_patent_app_number] => 12559305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/559305 | MOLECULES THAT SELECTIVELY HOME TO VASCULATURE OF PREMALIGNANT OR MALIGNANT LESIONS OF THE PANCREAS AND OTHER ORGANS | Sep 13, 2009 | Abandoned |
Array
(
[id] => 9140063
[patent_doc_number] => 08580520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'YKL-40 as a marker for gastrointestinal cancers'
[patent_app_type] => utility
[patent_app_number] => 13/063402
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 45
[patent_no_of_words] => 50259
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063402
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063402 | YKL-40 as a marker for gastrointestinal cancers | Sep 13, 2009 | Issued |
Array
(
[id] => 6390963
[patent_doc_number] => 20100303715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Prostate-specific membrane antigen and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/584852
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 131
[patent_figures_cnt] => 131
[patent_no_of_words] => 34921
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303715.pdf
[firstpage_image] =>[orig_patent_app_number] => 12584852
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/584852 | Prostate-specific membrane antigen and uses thereof | Sep 10, 2009 | Abandoned |
Array
(
[id] => 10033753
[patent_doc_number] => 09075065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Prostate cancer biomarker'
[patent_app_type] => utility
[patent_app_number] => 13/063320
[patent_app_country] => US
[patent_app_date] => 2009-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3568
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063320
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063320 | Prostate cancer biomarker | Sep 9, 2009 | Issued |
Array
(
[id] => 6374871
[patent_doc_number] => 20100081192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'EARLY PROSTATE CANCER ANTIGENS (EPCA), POLYNUCLEOTIDE SEQUENCES ENCODING THEM, AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 12/550903
[patent_app_country] => US
[patent_app_date] => 2009-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19630
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081192.pdf
[firstpage_image] =>[orig_patent_app_number] => 12550903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/550903 | EARLY PROSTATE CANCER ANTIGENS (EPCA), POLYNUCLEOTIDE SEQUENCES ENCODING THEM, AND THEIR USE | Aug 30, 2009 | Abandoned |
Array
(
[id] => 6307590
[patent_doc_number] => 20100069470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'IDENTIFICATION OF PROTEIN BIOMARKERS ASSOCIATED WITH LYMPH NODE METASTASIS IN COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/551168
[patent_app_country] => US
[patent_app_date] => 2009-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23039
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12551168
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/551168 | IDENTIFICATION OF PROTEIN BIOMARKERS ASSOCIATED WITH LYMPH NODE METASTASIS IN COLORECTAL CANCER | Aug 30, 2009 | Abandoned |